RESEARCH ROUNDUP

HTTPS://COMMONS.WIKIMEDIA.ORG/WIKI/USER:YAMAVU
After 10 months of delays, BC Cancer continues to wait for Health Canada approval on a $1M randomized, double-blind, placebo-controlled study on the effects of cannabis on cancer-related symptoms.Vancouver Sun
- Clinical lead Dr. Pippa Hawley originally expected to be able to begin recruiting patients in June, to deliver results within a year.
- Delays were partly due to Whistler Medical Marijuana, the LP from which researchers had . . .
Log in or become a WeedWeek Member to read this article.